Contract Research Organisations (CROs) are often associated with the operational side of clinical trials: patient recruitment, data management, site monitoring and logistics. While those tasks
We are pleased to share that the first patient has now been dosed in a Phase 2 clinical trial – a study exploring a new,
If you’re a researcher with a promising therapeutic, device or intervention, there comes a point where someone suggests taking it into a clinical trial. It
MAC Clinical Research is pleased to announce the successful dosing of the first participant in a Phase 2 clinical study investigating a psychedelic investigational compound
MAC Clinical Research and Kariya Pharmaceuticals are pleased to share the successful dosing of the first cohort in the Phase 1 Multiple Ascending Dose (MAD)
MAC Clinical Research (MAC) announces regulatory approval to initiate a PII clinical trial for mavatrep, an investigational, oral, TRPV1-receptor (transient receptor potential cation channel vanilloid
At MAC Clinical Research, we believe in transparency, collaboration, and driving conversations that matter in clinical research. Over the past months, we’ve worked closely with
Clinical research is constantly evolving, but one thing remains unchanged: the need for open conversations. From patient diversity and participant recruitment to operational processes and
April is Stress Awareness Month and a perfect opportunity to reflect on the stress in our lives and how we can effectively manage it. Stress
Taking a new treatment from lab to patient is a long, highly regulated process that demands years of research, significant investment and close collaboration between
